Foam Cells in Atherosclerosis: Novel Insights Into Its Origins, Consequences, and Molecular Mechanisms

Gui, Yuzhou, Zheng, Hongchao, Cao, Richard Y.·2022·Frontiers in Cardiovascular Medicine

Cited by (258)

Items 101–200 of 258

  1. The Multifaceted Role of Platelets in Atherosclerosis and Ischemic Disease: Pathogenesis, Inflammation, and Therapeutic Opportunities
    Sophia Strukel, Betelhem Teshome, Vikrant Rai · 2025 · Life
  2. Hyperglycemia-Induced Endothelial Dysfunction: From Classical Pathogenetic Mechanisms to Emerging Insights into ACE2 Protective Action
    Giada Lodi, Domenico Sergi, Anna Dipinto, Francesca Bompan, Paola Secchiero, Rebecca Voltan, Arianna Romani · 2026 · International Journal of Molecular Sciences
  3. Effects of diet-modulated gut microbiota and microbial metabolites in atherosclerosis
    Sunye Feng, Yujie Jiang, Jingting Jiang, Huimin Bian, Ruigong Zhu · 2026 · Biomedicine & Pharmacotherapy
  4. Role of Platelet Activating Factor as a Mediator of Inflammatory Diseases and Preterm Delivery
    Hanan Hamimi Wahid, Fatin N. Anahar, Nurul H. Isahak, Juwairiyah Mohd Zoharodzi, Siti N.L. Mohammad Khoiri, Nurul Hayati Mohamad Zainal, Norhidayah Kamarudin, Hamizah Ismail, Mohammed I. A. Mustafa Mahmud · 2024 · American Journal Of Pathology
  5. Unveiling the impact of TREM-2+ Macrophages in metabolic disorders
    Mike Contreras, Amanda de Oliveira Matos, Pedro Henrique dos Santos Dantas, José Rodrigues do Carmo Neto, Marcelle Silva‐Sales, Helioswilton Sales‐Campos · 2024 · Cellular Immunology
  6. HDL Cholesterol-Associated Shifts in the Expression of Preselected Genes Reveal both Pro-Atherogenic and Atheroprotective Effects of HDL in Coronary Artery Disease
    Alexander D. Dergunov, Elena V. Nosova, Alexandra V. Rozhkova, Margarita A. Vinogradina, Veronika B. Baserova, Mikhail Aleksandrovich Popov, Svetlana A. Limborska, Liudmila V. Dergunova · 2024 · Frontiers in Bioscience-Landmark
  7. Identification of Interactive Genetic Loci Linked to Insulin Resistance in Metabolic Syndrome—An Update
    Imadeldin Elfaki, Rashid Mir, Mohamed E. Elnageeb, Abdullah Hamadi, Zeyad M. Alharbi, Ruqaiah I. Bedaiwi, Jamsheed Javid, Tariq Alrasheed, Dalal Alatawi, Basmah M. Alrohaf et al. · 2025 · Medicina
  8. Recent Advances in the Mutual Regulation of m6A Modification and Non-Coding RNAs in Atherosclerosis
    Yanlu Wang, Sisi Ling, Hao Feng, Junkai Hua, Zhiyu Han, Renjie Chai · 2025 · International Journal of General Medicine
  9. The Role of Lipids in Atherosclerosis: Focus on Molecular Biology Mechanisms and Therapeutic Approaches
    Mohammed A. Akram, Abdelhamid Khodja, Sarah Dalibalta, Amin F. Majdalawieh · 2025 · Current Medicinal Chemistry
  10. Mitochondrial DNA in atherosclerosis research progress: a mini review
    Zheng Liu, Nan Huang, Chan Liu, Can Wu, Ling Zhou, Xiang Liu, Haibo Lei · 2025 · Frontiers in Immunology
  11. Aloe vera polysaccharides mitigate high-fat high-cholesterol diet-induced atherosclerosis in ApoE −/− mice via regulation of lipid metabolism and gut microbiota
    Shenji Yang, Xiao‐Jun Huang, Xiajialong Li, Jing Chun Feng, Peng Chen, Zhikang Cao, Luyao He, Chaojun Li, Zhipeng Li, Mingyong Xie · 2025 · Food & Function
  12. Anti-Atherogenic Mechanisms and Therapies
    Alex Hudson, Oluwakemi Osarumwense Igiehon, Matthew D. Woolard, Arif Yurdagul · 2025 · Current Atherosclerosis Reports
  13. Epigenetic‑ncRNA crosstalk in atherosclerosis: Mechanisms, disease progression and therapeutic potential (Review)
    Ying Zhu, Zhixin Hu, Jianshuo Liu, Huaqing Duan, Jiqiang Zeng, Xiaosheng Li, Yang Tang, Ziling Song, Zhipeng Wu, Shanrong Zhang et al. · 2025 · International Journal of Molecular Medicine
  14. Unearthing nature's remedy: An exploration into Lycopodium's medicinal and therapeutic potential
    Sara Anjum Niinuma, Aiman D. Khudair, Haniya Habib, Ahmed D. Khudair, Grahame Mackenzie, Stephen Lawrence Atkin, Alexandra E. Butler · 2024 · Applied Materials Today
  15. Aldosterone-Induced Transformation of Vascular Smooth Muscle Cells into Macrophage-like Cells Participates in Inflammatory Vascular Lesions
    Boya Zhang, Ziqian Liu, Yi Yao Chang, Ruyan Lv, Haixia Guo, Panpan Qiang, Tatsuo Shimosawa, Qingyou Xu, Fan Yang · 2025 · International Journal of Molecular Sciences
  16. Regulation of Atherosclerosis by Toll‐Like Receptor 4 Induced by Serum Amyloid 1: A Systematic In Vitro Study
    Jinhui Chen, Gang Liu, Yan Hong, Jing Han, Zhe Yang, Yanping Yang, Hong Li, Shumin Wang, Lili Jue, Qi Wang · 2022 · BioMed Research International
  17. Understanding autoimmunity in atherosclerosis paves the way for novel therapies
    Andreas Edsfeldt, Jan Åke Nilsson · 2023 · Nature Cardiovascular Research
  18. CD47-SIRPα signaling-inspired engineered monocytes for preventing the progression of atherosclerotic plaques
    Qing Xia, Feila Liu, Yue Zhou, Guanyuan Yang, Fangzhou Li, Tingting Liang, Jun Liu, Wanling Li, Yaqing Huang, Chuhong Zhu · 2024 · Materials Today Bio
  19. Wall Shear Stress (WSS) Analysis in Atherosclerosis in Partial Ligated Apolipoprotein E Knockout Mouse Model through Computational Fluid Dynamics (CFD)
    Minju Cho, Joon Seup Hwang, Kyeong Ryeol Kim, Jun Ki Kim · 2024 · International Journal of Molecular Sciences
  20. Preclinical evaluation of high-resolution CT, 18F-FDG, and 18F-NaF PET imaging for longitudinal monitoring of atherosclerosis
    Mikayla Tamboline, Jeffrey Collins, William Jackson, Wenduo Gu, Matthew D. Worssam, Paul P. Cheng, John David, Richard Taschereau, Arion F. Chatziioannou, Simon M. Jackson et al. · 2025 · European Journal of Nuclear Medicine and Molecular Imaging
  21. Anti-inflammatory interventions in coronary artery disease: antipodal responses requiring targeted therapeutic strategies
    Konstantinos E. Iliodromitis, Melchior Seyfarth, Zsuzsanna Balogh, Harilaos Bogossian, Efstathios K. Iliodromitis, Filippos K. Triposkiadis · 2025 · Basic Research in Cardiology
  22. Gut commensal microbiota drive tailored macrophage responses
    Joshua P. Jones, Karla Yvonne García-Martínez, Yi-Yuan Lee, Matthew W. Rhee, Rahul R. Nath, Sola Takahashi, Benjamin Grodner, Iwijn De Vlaminck, Cynthia Anne Leifer, Ilana Brito · 2025 · Cell Reports
  23. Monocytes/Macrophages and Atherogenesis
    Sergey G. Kozlov, T A Riazantseva, Ivan Melnikov, Sergey Okhota, Viktoriia Vasenkova, O. Saburova, Yuliya Avtaeva, Konstantin G. Guria, L. V. Prokofieva, Габбасов Зуфар Ахнафович · 2025 · International Journal of Molecular Sciences
  24. OGT deficiency in vascular smooth muscle orchestrates foam cell formation and PANoptosis during atherosclerotic progression
    Boao Liu, Huiping Ma, Yunxuan Guo, Hao Luo, Jie Ma, Shengqi Fu, Lin Xu, Xiwen Xiong · 2025 · Atherosclerosis
  25. Meteorin-like protein inhibits vascular smooth muscle cell-derived foam cell formation and atherosclerosis via KIT- endoplasmic reticulum stress signaling
    Chen Xu, Xueying Jiang, Siyu Hou, Fengling Lai, Keqing Hu, Jie Li, Ting Yang, Xinxin Shen, Huimin Chen, Shen Chen et al. · 2025 · Metabolism
  26. The critical role of inflammation in atherosclerotic coronary artery heart disease
    Joseph S. Spindler, Robert J. Henning · 2026 · Current Problems in Cardiology
  27. Cellular FXIII in Human Macrophage-Derived Foam Cells
    Laura Somodi, Emőke Horváth, Helga Bárdos, Barbara Baráth, Dávid Pethő, Ëva Katona, József Balla, Nicola J. Mutch, László Muszbek · 2023 · International Journal of Molecular Sciences
  28. Exosomes in Atherosclerosis: Role in the Pathogenesis and Targets for Therapy
    Siarhei A. Dabravolski, Vasily N. Sukhorukov, Victor Yu. Glanz, Elizaveta Pleshko, Nikolay A. Orekhov, Igor Alexandrovich Sobenin · 2024 · Current Medicinal Chemistry
  29. Amentoflavone for treating cardiocerebrovascular diseases and neurological disorders
    Hang Zhang, Yin-mei Ban, De-mei Li, Gang Wang, Juan Gu, Lei Zhu · 2024 · Frontiers in Pharmacology
  30. The role of splicing events in the inflammatory response of atherosclerosis: molecular mechanisms and modulation
    Aolong Wang, Chengzhi Wang, Bihan Xuan, Yanqin Sun, Bin Li, Qifei Zhao, Rui Yu, Xinlu Wang, Mingjun Zhu, Jingjing Wei · 2024 · Frontiers in Immunology
  31. From Dysbiosis to Cardiovascular Disease: The Impact of Gut Microbiota on Atherosclerosis and Emerging Therapies
    Tiago Lima, Verónica Costa, Carla Nunes, Gabriela Silva, Sara Domingues · 2025 · Applied Sciences
  32. An anti-inflammatory Glyburide-loaded nanoghost for atherosclerosis therapy: A red blood cell based bio-mimetic strategy
    Zahra Karami, Mohammad Akrami, Jalil Mehrzad, Mehdi Esfandyari‐Manesh, Ismaeil Haririan, Saeid Nateghi · 2023 · Giant
  33. IRF9 and STAT1 as biomarkers involved in T-cell immunity in atherosclerosis
    Wei Xie, Xiang Gao, Liang Zhao, Shifei Song, Na Li, Junming Liu · 2024 · Journal of Biosciences
  34. Animal models and lysosomal pathogenesis of atherosclerosis
    Zhengchao Wang, Xiang Li, Alexandra K. Moura, Jenny Z. Hu, Yunting Wang, Yang Zhang · 2025 · Animal Advances
  35. Green Tea Pressurized Hot Water Extract in Atherosclerosis: A Multi-Approach Study on Cellular, Animal, and Molecular Mechanisms
    Rahni Hossain, Anawat Kongchain, Moragot Chatatikun, Wiyada Kwanhian Klangbud, Chutha Takahashi Yupanqui, Hideyuki J. Majima, Hiroko P. Indo, Pradoldej M Sompol, Nazım Şekeroğlu, Atthaphong Phongphithakchai et al. · 2025 · Antioxidants
  36. Syringin and Phillygenin—Natural Compounds with a Potential Role in Preventing Lipid Deposition in Macrophages in the Context of Human Atherosclerotic Plaque
    Agnieszka Filipek, Agnieszka Sadowska, Monika Skłodowska, Maja Muskała, Edyta Czepielewska · 2025 · International Journal of Molecular Sciences
  37. KLF15 Transcriptionally Activates ATG14 to Promote Autophagy and Attenuate Damage of ox-LDL-Induced HAECs
    Dong Han, Ming Bo Huang, Zhen Chang, Wei Sun · 2023 · Molecular Biotechnology
  38. Identification of PPARG as key gene to link coronary atherosclerosis disease and rheumatoid arthritis via microarray data analysis
    Zhenzhen Zhang, Yupeng Chen, Xiaodan Fu, Linying Chen, Junlan Wang, Qingqiang Zheng, Sheng Zhang, Xia Zhu · 2024 · PLoS ONE
  39. Helicobacter cinaedi bacterium association with atherosclerosis and other diseases
    Alice K. Voronina, Georgij P. Arapidi · 2024 · Frontiers in Microbiology
  40. Computational approaches to investigate the relationship between periodontitis and cardiovascular diseases for precision medicine
    Sophia Duenas, Zachary McGee, Ishani Mhatre, Karthikeyan Mayilvahanan, Kush Ketan Patel, Habiba Abdelhalim, Atharv Jayprakash, Uzayr Wasif, Oluchi Nwankwo, William DeGroat et al. · 2024 · Human Genomics
  41. Vaccination as a Promising Approach in Cardiovascular Risk Mitigation: Are We Ready to Embrace a Vaccine Strategy?
    Georgios Tsioulos, Natalia G. Vallianou, Alexandros Skourtis, Μaria Dalamaga, Evangelia Kotsi, Sofia Kargioti, Nikolaos Adamidis, Ιrene Karampela, Iordanis S. Mourouzis, Dimitris C. Kounatidis · 2024 · Biomolecules
  42. Synergistic effects of notoginsenoside R1 and saikosaponin B2 in atherosclerosis: A novel approach targeting PI3K/AKT/mTOR pathway and macrophage autophagy
    Yihua Wang, Qing Liao, Xue Mei, Xu Han, Lijun Luo, Rong Huang, Yue Tang, Chunyang Zhou · 2025 · PLoS ONE
  43. Overexpression of TRPV6 Inhibits Coronary Atherosclerosis–Related Inflammatory Response and Cell Apoptosis via the PKA/UCP2 Pathway
    Lei Zheng, Huiying Zhang, Xuewen Li · 2024 · Cardiovascular Therapeutics
  44. Ark Shell-Derived Peptides AWLNH (P3) and PHDL (P4) Mitigate Foam Cell Formation by Modulating Cholesterol Metabolism and HO-1/Nrf2-Mediated Oxidative Stress in Atherosclerosis
    Chathuri Kaushalya Marasinghe, Jae‐Young Je · 2025 · Marine Drugs
  45. Proteotoxic stress response in atherosclerotic cardiovascular disease: Emerging role of heat shock factor 1
    Shruti Ghai, Alex Young, Kuo‐Hui Su · 2023 · Frontiers in Cardiovascular Medicine
  46. Capturing in-vitro electro-mechanochemical signals in a label-free drug testing system for atherosclerosis
    Abhijit Lincon, Sandeep Kumar Yadav, Subhayan Das, Mahitosh Mandal, Sunando DasGupta, Soumen Das · 2024 · Sensors and Actuators B Chemical
  47. Amino Acid Metabolism and Autophagy in Atherosclerotic Cardiovascular Disease
    Yuting Wu, Irem Avcilar-Kücükgöze, Donato Santovito, Dorothee Atzler · 2024 · Biomolecules
  48. Discovery and in vitro characterization of a human anti-CD36 scFv
    Cecilia Mata-Cruz, Sandra Guerrero-Rodríguez, Keyla Gómez-Castellano, Gregorio Carballo‐Uicab, Juan Carlos Almagro, Sonia Mayra Pérez‐Tapia, Marco Antonio Velasco-Velázquez · 2025 · Frontiers in Immunology
  49. Advancing the Landscape of RNAi Nanotherapeutics for Ischemic Heart Disease
    Han Gao, Da Pan, Hélder A. Santos · 2026 · Advanced Materials
  50. PANoptosis and cardiovascular disease: The preventive role of exercise training
    Negin Kordi, Masoumeh Sanaei, Peyman Akraminia, Sajad Yavari, Ali Saydi, Fatemeh Khamis Abadi, Naser Heydari, Friedrich Jung, Sajad Karami · 2024 · Clinical Hemorheology and Microcirculation
  51. Potent lipid-lowering, antioxidant, and cardioprotective effects of combined Moringa oleifera and Curcuma longa extracts in hypercholesterolemic rats
    Karima Dahili, Djamil Krouf, Lynda Hamedi, Ismahene Bourouina, Nawal Dida · 2025 · South African Journal of Botany
  52. Mechanism of salvianolic phenolic acids and hawthorn triterpenic acids combination in intervening atherosclerosis: network pharmacology, molecular docking, and experimental validation
    Qu Zhai, Shanfei Shang, Zihan Zhang, Lihua Sun, Ying‐Che Huang, Shuyi Feng, Qian Wu, Haifeng Cui, Xiaolu Shi · 2025 · Frontiers in Pharmacology
  53. Ertugliflozin attenuates atherosclerosis in nondiabetic ApoE−/− mice by upregulating ABCA1 and LDLR via the PPARγ/LXRα pathway
    Jing Yang, Baixue Zhang, Faming Zhao, Yue Wang, Bo Li, Yuanbao Dong · 2025 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  54. Exploring Macrophage Contribution to Vascular Calcification in Atherosclerosis
    Siarhei A. Dabravolski, Mikhail Aleksandrovich Popov, Olga Nikolaevna Maltseva, Vsevolod Vyacheslavovich Pavshintsev, Aleksandra Sergeevna Utkina, Alexander Nikolaevich Orekhov · 2025 · IUBMB Life
  55. Death as rebirth: how efferocytosis drives tissue repair and disease treatment
    Xinliang Duan, Sichen Han, Yifu Bian, Yao Yuan, Jiayu Shen, Yixuan Dai, Junzi Mi, Zilin Wang · 2026 · Frontiers in Immunology
  56. Long non-coding RNA AK023617 orchestrates atherosclerosis by regulating the circadian rhythm of immunity-related GTPase family M protein in macrophages
    Rongzhe Lu, Hengxuan Cai, Yige Liu, Guanpeng Ma, Jiaxin Wang, Miao Yan, Zhenming Zhang, Bo Yu, Zhaoying Li, Shaohong Fang · 2024 · Non-coding RNA Research
  57. Mycoplasma pneumoniae drives macrophage lipid uptake via GlpD-mediated oxidation, facilitating foam cell formation
    Takeshi Yamamoto, Miki Okuno, Koichi Kuwano, Yoshitoshi Ogura · 2025 · International Journal of Medical Microbiology
  58. A Bibliometric Analysis of Strategies for Atherosclerosis Treatment with Organic Nanoparticles
    Jizhuang Ma, Xia Zhao, Xinwen Xu, A Lixin, Qiang Liu, Peng Qu · 2025 · Pharmaceutics
  59. miRNA Dysregulation of AGE/RAGE Pathway in Metabolic Syndrome: A Novel Analysis Strategy Utilizing miRNA-profiling Data
    Maria Bograya, S. S. Voronova, Mikhail Lopatin, Maria Vulf, Н. М. Тодосенко, Litvinova Larisa · 2025 · Gene Expression
  60. Omics research in atherosclerosis
    Kai-Jiang Tian, Yang Yu, G. Chen, Nian-Hua Deng, Zhen Tian, Rui Bai, Fan Zhang, Zhi-Sheng Jiang · 2024 · Molecular and Cellular Biochemistry
  61. Administration of the KCa channel activator SKA-31 improves endothelial function in the aorta of atherosclerosis-prone mice
    O. Daniel Vera, Ramesh C. Mishra, Rayan Khaddaj‐Mallat, Liam Hamm, Barak Almarzouq, Yong-Xiang Chen, Darrell D. Belke, Latika Singh, Heike Wulff, Andrew P. Braun · 2025 · Frontiers in Pharmacology
  62. The Acari Hypothesis, VII: accounting for the comorbidity of allergy with other contemporary medical conditions, especially metabolic syndrome
    Andrew C. Retzinger, Gregory S. Retzinger · 2025 · Frontiers in Allergy
  63. Salusins in Atherosclerosis: Dual Roles in Vascular Inflammation and Remodeling
    Leszek Niepolski, Szymon Jęśko-Białek, Joanna Niepolska, Agata Pendzińska · 2025 · Biomedicines
  64. Exendin-4 Prevents oxLDL-Induced upregulation of TREM2 and attenuates foam cell formation and inflammation in Macrophages.
    Xu Wang, Meng-Ting Jiang, Hailong Bao, Run-Ze Huang, Bingxiu Chen, Chang-Fan Wu, Hongwei Wang, Zhen-Hua Luo, Wei Li · 2025 · Biochemical Pharmacology
  65. Targeted Theranostic Strategy for Atherosclerotic Plaques Using Intravascular Multimodal Imaging Techniques
    Jin Hyuk Kim, Hongki Yoo, Kyeongsoon Park, Jin Won Kim · 2025 · Journal of Lipid and Atherosclerosis
  66. Cathepsin C: a critical mediator between immune response and cardiovascular disease – therapeutic implications of enzyme inhibition
    Alaa A. A. Aljabali, Mohammad A. Obeid, Omar Gammoh, Walhan Alshaer, Esam Y. Qnais, Abdelrahim M. Alqudah, Vijay Kumar Mishra, Yachana Mishra, Mohamed El‐Tanani · 2025 · Drug Development and Industrial Pharmacy
  67. Influence of LDL cholesterol and Lp(a) on monocytes and macrophages in atherosclerosis
    Sabina Ugovšek, Jernej Jeras, Miran Šebeštjen, Janja Zupan · 2025 · Biochemia Medica
  68. Exposure to a PFAS mixture alters cholesterol lipoprotein subfractions and induces a foam cell-like aortic macrophage expression profile in hyperlipidemic LDLr−/− mice
    Katherine Roth, Zhao Yang, Manisha Agarwal, Katherine Gurdziel, Michael C. Petriello · 2025 · Toxicology and Applied Pharmacology
  69. D-limonene modulates AMPK signaling to inhibit ox-LDL-induced foam cell formation
    Guangyu Luo, Fang Fang, Yanyan Guo, Yue Li, Xin Luo · 2025 · Scientific Reports
  70. LncRNA H19 drives atherosclerosis progression via the miR-let-7a/ITGB3 axis
    Zi-yang Hu, Li Y, Long-Yu Liu, Xiaoyan Chen, Kai-xuan Lin, Abdallah Iddy Chaurembo, Xue-Shan Li, Guo-Qiang Huang, Xiao-Qian Wu, Zi-feng Huang et al. · 2026 · Frontiers in Physiology
  71. Recent advances in nanodelivery systems of drugs and genes for atherosclerosis: Fundamentals, mechanisms, applications
    Yutao Wang, Yijie Zhang, Zhiye Bao, Danyang Li, Seid Mahdi Jafari, Qi Pan · 2026 · Advances in Colloid and Interface Science
  72. Metformin as a multi-target modulator of atherosclerosis: integrated regulation of Nrf2/KLF2, mitochondrial homeostasis, inflammation, ferroptosis, and innate immunity
    Mansour Alanazi, Hayder Mutter Al-Kuraishy, Aya M. Mustafa, Mubarak Alruwaili, Athanasios T. Alexiou, Marios Papadakis, Gaber El‐Saber Batiha · 2026 · Journal of Pharmacy and Pharmacology
  73. Emerging insights into inflammation-driven atherosclerosis: immune cell mechanisms
    Abdullahi Osman Mohamud, Zhiyin Dai · 2026 · Frontiers in Cardiovascular Medicine
  74. Polycyclic Tetramate Macrolactams and Their Potential as Anticancer Agents
    Alexandria Montavon, M. Raquel Marchán-Rivadeneira, Yong Han · 2024 · Organics
  75. Regrettable Substitution? Organophosphate Flame Retardants and Macrophage Activity
    Nate Seltenrich · 2024 · Environmental Health Perspectives
  76. FBXL14 inhibits foam cell formation and atherosclerosis plaque progression by activating the NRF2 signal axis through ubiquitination of DUSP6
    Wenjie Luo, Yubin Chen, Cheng Fang, Hui Shi, Fanyan Luo · 2025 · Journal of Receptors and Signal Transduction
  77. Adiponectin and TNF-Alpha Differentially Mediate the Association Between Cystatin C and Oxidized LDL in Type 2 Diabetes Mellitus Patients
    Ahmed Bakillah, Ayman Farouk Soliman, Maram AlSubaiee, Khamess O. Khamees, Arwa Al Hussaini, Shahinaz Faisal Bashir, Mohammad Al Arab, Abeer Al Otaibi, Sindiyan Al Shaikh Mubarak, Ali Ahmed Al Qarni · 2025 · International Journal of Molecular Sciences
  78. Effects of Gold Nanoparticles Functionalized with Cornus mas L. Fruit Extract on the Aorta Wall in Rats with a High-Fat Diet and Experimental-Induced Diabetes Mellitus—An Imaging Study
    Remus Moldovan, Daniela-Rodica Mitrea, Adrian Florea, Luminița David, Laura Elena Muresan, Irina Camelia Chiş, S. Suciu, Bianca Elena Moldovan, Manuela Lenghel, Liviu Chiriac et al. · 2023 · Nanomaterials
  79. Structural, functional and biochemical characterisation of apolipoprotein(a)-containing low-density lipoproteins
    Yubexi Correa, Favour Amarachi Nzekwe, Tigist Wodaje, Jonas W. Brinck, Martin Jansen, Clement Emmanuel Blanchet, Jan Skov Pedersen, Rita Del Giudice, Marité Cárdenas · 2025 · Journal of Colloid and Interface Science
  80. Alterations of Bioactive Lipid Profiles in the Retina Following Traumatic Optic Neuropathy in Mice
    Min Young Kim, Nandini Koneru, Gieth Alahdab, Michael L. Risner, Ahmed S. Ibrahim, Krishna Rao Maddipati, Mohamed Al‐Shabrawey · 2025 · Biomolecules
  81. Solanum mauritianum Scop. Leaf Extract Attenuates ROS-Mediated Inflammation and Prevents IL-6 Promoter Demethylation in Activated Monocytes
    Aswathy Karanath‐Anilkumar, Muhammad Sadiq, Swamynathan Ganesan, Shiek S. S. J. Ahmed, Ganesh Munuswamy‐Ramanujam · 2025 · Applied Biochemistry and Biotechnology
  82. Effect of Oral Hypoglycaemic Agents on Carotid Artery Intima‐Media Thickness in Patients With Cardiovascular Disease and/or Diabetes—A Systematic Review
    Ali Shabu, Syed Mohammad Naqvi, Farshad Hesari, Syed Yaseen Naqvi, Wael A. Tawfick · 2025 · Endocrinology Diabetes & Metabolism
  83. Tumour-Associated MUC1 Exerts Multiple Effects on Cholesterol and Lipid Metabolism—A Potential Pathogenic Effector of Atherosclerosis in Cancer
    Yunliang Chen, M. F. Scully · 2026 · International Journal of Molecular Sciences
  84. Plant Derived Bioactives
    Ruth T. Boachie, Raliat O. Abioye, Rotimi Emmanuel Aluko · 2025 · Elsevier eBooks
  85. Conditioned medium from 1-nitropyrene induced THP-1 foam cells promotes pro-tumorigenesis in lung epithelial cells.
    Ankita Bagde, Atul Katarkar, K. Krishnamurthi · 2026 · Toxicology in Vitro
  86. Phytochemicals alter foam cell formation and macrophage cholesterol efflux
    Z. Pan, Wenhua Ling · 2026 · Metabolism and Diseases
  87. Caspase Recruitment Domain Family Member 8: A Favorable Target in the Pathogenesis of Atherosclerosis
    Dandan Tian, L H Liu, Guang-Gui Zeng, Jinrong He, Huiqin Liu, Dandan Ma, Zixin Yang, Xiangyan Ma, Yunxiang Cao, Chunyan Xu · 2026 · Reviews in Cardiovascular Medicine
  88. Targeting inflammation in atherosclerosis: prospects and limitations
    Dmitriy A. Tanyanskiy, Alexander D. Denisenko, Peter V. Pigarevsky · 2025 · Cytokines and inflammation
  89. Hexosamine Biosynthetic Pathway and Fatty Acid β-Oxidative Imbalance: A Key Mechanism by Which Abnormal Macrophage Lipophagy Promotes Atherosclerosis in Diabetes
    Jinping Liu, Yu-hui Liu, Hao Luo, Shuai-yi Yu, Shuai-yi Yu, Ya Wu, Yong Liu · 2026 · Cardiovascular Drugs and Therapy
  90. Atherogenic-like lesions associated with a progressive chronic vascular degeneration in a rat model of repetitive low-level blast brain injury
    Miguel A. Gama Sosa, Rita De Gasperi, Rachel H Lind, Dylan Pryor, Gissel M. Perez, Georgina S. Perez Garcia, Rania Abutarboush, Usmah Kawoos, Carolyn Wei Zhu, William G.M. Janssen et al. · 2026 · Journal of Neuropathology & Experimental Neurology
  91. Organoid models reveal mechanistic connections and sirolimus efficacy in liver-vascular steatosis and foam cell formation
    Vishnu Goutham Kota, Jordan Low Jun Yi, Zhiyi Zhang, Apisara Yooyuen, Hanry Yu, Hwa Liang Leo · 2026 · Atherosclerosis
  92. Host–Microbiota Metabolic Interactions in Atherosclerosis: Oral, gut, and Blood Perspectives
    Ikram Khan, Muhammad Irfan, Ali Sher Bacha, Imran Khan, Yasir Ali, Li Zhiqiang · 2026 · Probiotics and Antimicrobial Proteins
  93. Efficacy of Watercress (Nasturtium officinale R.Br.) Consumption on Blood Pressure, Oxidative Stress Biomarkers, and Estimated Cardiovascular Risk in Thai Middle-Aged Adults: A Randomized Placebo-Controlled Pilot Study
    Praporn Kijkuokool, Kittipan Rerkasem, Puriwat Fakfum, Wason Parklak, Hataichanok Chuljerm, Wiritphon Khiaolaongam, Chikondi Maluwa, Kanokwan Kulprachakarn · 2026 · Antioxidants
  94. Olfactomedin 2 Promotes Atherosclerosis by Eliciting Smooth Muscle Foam Cell Formation
    Ning Shi, Dunpeng Cai, Bysani Chandrasekar, Yusuke Higashi, Shi‐You Chen · 2026 · Arteriosclerosis Thrombosis and Vascular Biology
  95. AIEgen‐Based Biomimetic Nanoplatform for Targeted Synergistic Sonodynamic Therapy and Macrophage Reprogramming of Hyperhomocysteinemic Atherosclerosis
    Yue Jia, Bin Li, Qin Gu, Yunlong Zhang, Shuo Sang, Fei Ma, Changting He, Yongli Wang, Yanqiu Wu, Duo Jiang et al. · 2026 · Small
  96. Macrophage-Targeted ROS-Responsive Nanoplatform for Coordinated NF-κB and Nrf2 Modulation in Atherosclerosis Therapy
    Jin Liu, Bo Li, Yunlong Tian, Huan Zhang, Yanan Shi, Sha Liu · 2026 · ACS Applied Materials & Interfaces
  97. A Portable Neck-Surface Piezoelectric Sensor for Evaluating Subclinical Carotid Atherosclerosis via Snoring Vibratory Analysis: An Exploratory Dual-Modality Study
    Li‐Ang Lee, Li‐Pang Chuang, Guo‐She Lee, Cheng-Kuo Lai, Huei-Dan Cheng, Zixuan Huang, Zong-Han Lee, Liang-Yu Shyu, Hsueh‐Yu Li, Chi‐Hung Liu et al. · 2026 · Biosensors
  98. Deciphering Structural Dynamics of Atherosclerosis Proteins: Insights from Crataegus oxyacantha Phytochemicals that Interceded Functional and Structural Changes in Targeted Atherosclerotic Proteins
    Praveen Jeeva, Anusuyadevi Muthusamy, Jayachandran Kesavan swaminathan · 2024 · ACS Omega
  99. PROSTATE CELL HETEROGENEITY AND CXCL17 UPREGULATION IN MOUSE STEROID HORMONE IMBALANCE
    Samara V. Silver, Kayah J. Tucker, Renee E. Vickman, Nadia A. Lanman, O. John Semmes, Nehemiah S. Alvarez, Petra Popovics · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  100. Application of stem cells in the treatment of trophic ulcers of venous genesis
    V.V. Melnyk, V.V. Kryvetskyi, Dmytro Volodymyrovych Proniaiev, V.L. Voloshyn, O. V. Kolesnik · 2022 · Bukovinian Medical Herald